Evidence map›Paper›PMID 26810301›Full record

ArticlePharmaceutical biology2016

Chlorogenic acid protects D-galactose-induced liver and kidney injury via antioxidation and anti-inflammation effects in mice.

Yan Feng, Ying-Hua Yu, Shu-Ting Wang, Jing Ren, Danielle Camer, Yu-Zhou Hua, Qian Zhang, Jie Huang, Dan-Lu Xue, Xiao-Fei Zhang and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Pharmaceutical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Protective Effects of Methanolic Extract ofInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Synergistic Effect of Banaba Leaf Extract and Policosanol (RaydelPharmaceuticals (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Beeswax Alcohol (BWA, RaydelPharmaceuticals (Basel, Switzerland) · 2024
    Article
  14. Review
  15. Review
  16. Bioinformation · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Yan Fenga Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Xuzhou Medical College , Xuzhou , Jiangsu , China ;
Ying-Hua Yub Schizophrenia Research Institute (SRI) , Sydney , NSW , Australia ;
Shu-Ting Wanga Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Xuzhou Medical College , Xuzhou , Jiangsu , China ;
Jing Rena Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Xuzhou Medical College , Xuzhou , Jiangsu , China ;
Danielle Camerc Illawarra Health and Medical Research Institute, School of Medicine, University of Wollongong , NSW , Australia.
Yu-Zhou Huaa Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Xuzhou Medical College , Xuzhou , Jiangsu , China ;
Qian Zhanga Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Xuzhou Medical College , Xuzhou , Jiangsu , China ;
Jie Huanga Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Xuzhou Medical College , Xuzhou , Jiangsu , China ;
Dan-Lu Xuea Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Xuzhou Medical College , Xuzhou , Jiangsu , China ;
Xiao-Fei Zhanga Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Xuzhou Medical College , Xuzhou , Jiangsu , China ;
Xu-Feng Huangb Schizophrenia Research Institute (SRI) , Sydney , NSW , Australia ;
Yi Liua Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Xuzhou Medical College , Xuzhou , Jiangsu , China ;
Xuzhou Medical College · CNIllawarra Health and Medical Research Institute · AUSchizophrenia Research Institute · AUUniversity of Wollongong · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextOxidative stress and inflammation are implicated in the aging process and its related hepatic and renal function decline. Chlorogenic acid (CGA) is one of the most abundant polyphenol compounds in the human diet. Recently, CGA has shown in vivo and in vitro antioxidant properties.

objectiveThe current study investigates the effects of protective effects of chlorogenic acid (CGA) on D-galactose-induced liver and kidney injury. MATERIALS AND

methodsHepatic and renal injuries were induced in a mouse model by subcutaneously injection of D-galactose (D-gal; 100 mg/kg) once a day for 8 consecutive weeks and orally administered simultaneously with CGA included in the food (200 mg/kg of diet). The liver and renal functions were examined. Histological analyses of liver and kidney were done by haematoxylin and eosin staining. The oxidative stress markers and pro-inflammatory cytokines in the liver and the kidney were measured. Results CGA significantly reduced the serum aminotransferase, serum creatinine (SCr) and blood urea nitrogen (BUN) levels in D-gal mice (p <0.05). CGA also restored superoxide dismutase, catalase, and malondialdehyde levels and decreased glutathione content in the liver and kidney in D-gal mice (p <0.05). Improvements in liver and kidney were also noted in histopathological studies. CGA reduced tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6) protein levels in the liver and kidney in D-gal mice (p <0.05). DISCUSSION AND

conclusionThese findings suggest that CGA attenuates D-gal-induced chronic liver and kidney injury and that this protection may be due to its antioxidative and anti-inflammatory activities.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsChemical and Drug Induced Liver InjuryChlorogenic AcidGalactoseInterleukin-6Kidney DiseasesKidney Function TestsLiver Function TestsMaleMice, Inbred StrainsOxidative StressTumor Necrosis Factor-alphaAnti-Inflammatory AgentsAntioxidantsChlorogenic AcidGalactoseInterleukin-6interleukin-6, mouseTumor Necrosis Factor-alphaCGAd-galoxidative stress

Identifiers

PMID26810301
PMCPMC11132915
OpenAlexW2255353690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.